Rendina foundation plans golf tourney, shares stories of cancer's impact on familyPalm Beach Daily NewsRendina underwent three cycles of Methotrexate, which slows the growth of cancer cells, and six cycles of R-CHOP, a therapy that adds the drug Ri…
Rendina foundation plans benefit golf tourney, shares stories of cancer's …Palm Beach Daily NewsRendina underwent three cycles of Methotrexate, which slows the growth of cancer cells, and six cycles of R-CHOP, a therapy that adds the drug Rituxim…
Georgetown University, hospitals audited for Medicare overpaymentsFierceHealthcareIn its review of injection drugs (doxorubicin hydrochloride liposome, rituximab, pemetrexed, cetuximab and epoetin alfa), OIG found that O'Connor Hospital in San Jose…
BIOGEN IDEC al 64mo INCONTRO ANNUALE DELL'AMERICAN ACADEMY OF NEUROLOGY (AAN)Italia NewsL'espansione di cellule Natural Killer CD56bright predice la risposta al trattamento con daclizumab HYP in casi di sclerosi multipla recidivante-remittente …
Nuevos datos presentados en el 64º Congreso Anual AAN destacan el compromiso …elEconomista.es… de investigación de su cartera en última fase, incluido: BG-12, interferón beta-1a PEGylado, y el proceso de alto rendimiento de daclizumab (DAC HYP)…
Haga doble click sobre una palabra para ver su signifcadoelEconomista.es… de investigación de su cartera en última fase, incluido: BG-12, interferón beta-1a PEGylado, y el proceso de alto rendimiento de daclizumab (DAC HYP) para EM; y dexpramipexo…
Biogen Idec to present new neurology data at AAN 2012 meetingZenopaNew data will highlight the safety and efficacy of the marketed products Tysabri, Avonex and Fampyra, as well as results from investigational trials of key late-stage compounds such as …
Belper NewsPenny's fund gigBelper NewsHer family and friends have raised thousands of pounds towards the cost of a drug called Rituximab, which is not available on the NHS in the East Midlands and costs £25000 a year. And to boost the fundraising …
Partager BFM surBFM Business… de son pipeline de molécules en phase finale, dont : BG-12, interféron bêta-1a pégylé et DAC HYP (procédé à haut rendement du daclizumab) pour la SEP ; et dexpramipexole, un traitement potentiel pour la sclérose…
Biogen Idec presenteert nieuwe data op American Academy of Neurology …Nieuws.nlDaarnaast presenteert Biogen Idec de resultaten van onderzoeksproeven zoals de BG-12, PEGylated interferon beta-1a, en daclizumab high-yield process (DAC HYP) voor multipl…